The Charles LeMoyne Hospital is the major hospital in Longueuil, Quebec, Canada. It is located on Taschereau Boulevard in the borough of Greenfield Park opposite the borough of Saint-Hubert and in close proximity to the LeMoyne neighbourhood in the borough of Le Vieux-Longueuil.

There are 571 beds in Centre de sante et de services sociaux Champlain Charles Le Moyne.

During the past decade, Centre de sante et de services sociaux Champlain Charles Le Moyne conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de sante et de services sociaux Champlain Charles Le Moyne" #1 sponsor was "Celgene" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de sante et de services sociaux Champlain Charles Le Moyne" #1 collaborator was "Biotronik Canada Inc" with 1 trials as a collaborator, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials as a collaborator, "Hopital Charles Lemoyne" with 1 trials as a collaborator, "Jewish Rehabilitation Hospital" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centre de sante et de services sociaux Champlain Charles Le Moyne" are "Ulcerative Colitis" (4 trials), "Crohn Disease" (2 trials), "Arteriovenous Fistulae" (1 trials), "Arteriovenous Graft" (1 trials) and "Castration-resistant Prostate Cancer Patients With Oligometastases" (1 trials). Many other conditions were trialed in "Centre de sante et de services sociaux Champlain Charles Le Moyne" in a lesser frequency.

Most popular intervention types in "Centre de sante et de services sociaux Champlain Charles Le Moyne" are "Drug" (10 trials), "Other" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "GED-0301" (3 trials), "Etrolizumab" (2 trials), "Enzalutamide" (1 trials) and "Everolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de sante et de services sociaux Champlain Charles Le Moyne" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre de sante et de services sociaux Champlain Charles Le Moyne". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre de sante et de services sociaux Champlain Charles Le Moyne, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de sante et de services sociaux Champlain Charles Le Moyne, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".